MONASH IVF GROUP LIMITED (MVF)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
![](/stocklogo/MVF.jpg)
MVF - MONASH IVF GROUP LIMITED
FNArena Sector :
Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.99
Index: ASX300 | ALL-ORDS
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.99
Monash IVF is an Australian provider of IVF, Ultrasound and genetic testing services throughout Australia and Asia. The company has been listed since 2014.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.345
25 Jul |
OPEN $1.34 |
HIGH $1.35 |
631,441 LOW $1.32 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLS . M7T . MDR . MPL . NHF . PSQ . RHC . SHL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 5.6 | 7.5 | xxx |
DPS (cps) | xxx | 4.4 | 5.0 | xxx |
EPS Growth | xxx | 18.6% | 34.4% | xxx |
DPS Growth | xxx | 0.0% | 14.2% | xxx |
PE Ratio | xxx | N/A | 17.5 | xxx |
Dividend Yield | xxx | N/A | 3.8% | xxx |
Div Pay Ratio(%) | xxx | 78.6% | 66.8% | xxx |
Last ex-div: 07/03 - ex-div 2.5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 5.6 |
DPS All | xxx | xxx | xxx | xxx | xxx | 4.4 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 213.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 70.1 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 38.0 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 10.22 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 8.07 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 6.20 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 5.40 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 8.07 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 9.70 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -7.0 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 6 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 94 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 100 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 255 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 8 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.63 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 27.8 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 13.01 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 150 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 28 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 2 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
![](/images/chart-unavailable.png)
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
MVF STOCK CHART
![](/wp-content/uploads/2020/10/img-side-banner-stock-analysis.jpg)
FNArena News on MVF
1 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 10-05-24May 10 2024 - Weekly Reports |
2 |
Australian Broker Call *Extra* Edition – May 07, 2024May 07 2024 - Daily Market Reports |
3 |
ESG Focus: Governance, Supply Chains, RisksApr 29 2024 - ESG Focus |
4 |
ESG Focus: Counting Psychosocial Costs On ASXApr 22 2024 - ESG Focus |
5 |
Rudi’s View: Healthcare Under The ScannerMar 13 2024 - Rudi's View |
Latest Healthcare services News
1 |
Building The No 3 Diagnostic Imaging PlayerJun 19 2024 - Small Caps |
2 |
Capitol Health’s Higher Margin OutlookMar 13 2024 - Small Caps |
3 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
4 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
5 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
6 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
7 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
8 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
9 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
10 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |